Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 19851-19900 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06271044
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
NA
Active, not recruiting
61 participants
Started: Oct 31, 2014 · Completed: Dec 31, 2027
1 condition
1 sponsor
0 locations
NCT02274116
Acute Intermittent Hypoxia on Leg Function Following Spinal Cord Injury
NA
Active, not recruiting
30 participants
Started: Oct 31, 2014 · Completed: Aug 31, 2024
1 condition
2 sponsors
1 location
NCT02292589
Brain Stimulation for Mild Traumatic Brain Injury
PHASE2
Active, not recruiting
20 participants
Started: Oct 31, 2014 · Completed: Apr 30, 2028
2 conditions
1 sponsor
1 location
NCT02446665
Disease Status in Primary Sclerosing Cholangitis by Elastography
NA
Active, not recruiting
82 participants
Started: Oct 31, 2014 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT02042807
To Evaluate the Effect of MCS® in Prostate Cancer Prevention
PHASE2
Active, not recruiting
702 participants
Started: Oct 31, 2014 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT02123056
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
PHASE4
Active, not recruiting
52 participants
Started: Oct 31, 2014 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT02286154
Therapeutic Response Evaluation and Adherence Trial (TREAT)
NA
Active, not recruiting
150 participants
Started: Oct 31, 2014 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT02400359
Lorcaserin in Obesity: Identification of CNS Targets Using FMRI
PHASE4
Active, not recruiting
40 participants
Started: Oct 31, 2014 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT02276885
Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial
NA
Active, not recruiting
284 participants
Started: Oct 28, 2014 · Completed: Dec 7, 2026
1 condition
1 sponsor
1 location
NCT02278744
Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery
PHASE1
Active, not recruiting
9 participants
Started: Oct 27, 2014 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02250937
Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
PHASE2
Active, not recruiting
116 participants
Started: Oct 27, 2014 · Completed: Oct 31, 2027
2 conditions
2 sponsors
1 location
NCT02281747
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
N/A
Active, not recruiting
521,292 participants
Started: Oct 24, 2014 · Completed: May 31, 2029
2 conditions
1 sponsor
1 location
NCT02231775
Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation
PHASE2
Active, not recruiting
58 participants
Started: Oct 22, 2014 · Completed: Apr 1, 2027
2 conditions
2 sponsors
1 location
NCT02251821
JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
PHASE2
Active, not recruiting
61 participants
Started: Oct 20, 2014 · Completed: Dec 28, 2025
2 conditions
3 sponsors
1 location
NCT02146924
Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia
PHASE1
Active, not recruiting
71 participants
Started: Oct 16, 2014 · Completed: Sep 24, 2025
3 conditions
2 sponsors
1 location
NCT01955460
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
PHASE1
Active, not recruiting
34 participants
Started: Oct 15, 2014 · Completed: Oct 30, 2027
6 conditions
2 sponsors
1 location
NCT02262806
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
PHASE2
Active, not recruiting
29 participants
Started: Oct 14, 2014 · Completed: Jul 31, 2027
3 conditions
1 sponsor
1 location
NCT02304809
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations
PHASE2
Active, not recruiting
216 participants
Started: Oct 13, 2014 · Completed: Oct 13, 2027
3 conditions
4 sponsors
1 location
NCT02156739
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NA
Active, not recruiting
100 participants
Started: Oct 13, 2014 · Completed: Jun 1, 2026
4 conditions
2 sponsors
1 location
NCT04286776
Memory Retrieval and Encoding Investigated by Neural Stimulation
NA
Active, not recruiting
800 participants
Started: Oct 12, 2014 · Completed: Dec 31, 2024
1 condition
3 sponsors
11 locations
NCT02227199
Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
45 participants
Started: Oct 10, 2014 · Completed: Sep 30, 2025
2 conditions
3 sponsors
1 location
NCT02143726
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
PHASE2
Active, not recruiting
35 participants
Started: Oct 9, 2014 · Completed: Aug 6, 2028
1 condition
3 sponsors
21 locations
NCT02221934
Electrical Nerve Block for Amputation Pain
NA
Active, not recruiting
607 participants
Started: Oct 9, 2014 · Completed: Sep 1, 2025
4 conditions
1 sponsor
22 locations
NCT02256137
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
N/A
Active, not recruiting
1,564 participants
Started: Oct 8, 2014 · Completed: Jun 1, 2027
3 conditions
2 sponsors
1 location
NCT02112916
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
PHASE3
Active, not recruiting
847 participants
Started: Oct 4, 2014 · Completed: Sep 16, 2026
8 conditions
1 sponsor
212 locations
NCT02152631
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
PHASE3
Active, not recruiting
453 participants
Started: Oct 3, 2014 · Completed: Dec 31, 2025
1 condition
1 sponsor
231 locations
NCT01972347
Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma
PHASE2
Active, not recruiting
35 participants
Started: Oct 1, 2014 · Completed: May 1, 2026
1 condition
1 sponsor
1 location
NCT02397434
Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer
NA
Active, not recruiting
76 participants
Started: Oct 1, 2014 · Completed: Oct 30, 2028
1 condition
1 sponsor
1 location
NCT02261389
Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET
NA
Active, not recruiting
1,507 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2030
1 condition
4 sponsors
7 locations
NCT02174926
LASER Trial. LAparoscopic Elective Sigmoid Resection Following divERticulitis - a Multicenter, Prospective, Randomized Clinical Trial
NA
Active, not recruiting
133 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2027
2 conditions
1 sponsor
11 locations
NCT02229422
A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Sep 30, 2014 · Completed: Dec 25, 2025
1 condition
2 sponsors
1 location
NCT02336217
Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
NA
Active, not recruiting
40 participants
Started: Sep 30, 2014 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT02332356
Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease
PHASE3
Active, not recruiting
100 participants
Started: Sep 30, 2014 · Completed: Mar 31, 2024
1 condition
1 sponsor
1 location
NCT02192398
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NA
Active, not recruiting
120 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT01985087
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Sep 30, 2014 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT02389244
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
PHASE2
Active, not recruiting
163 participants
Started: Sep 30, 2014 · Completed: Mar 11, 2026
5 conditions
1 sponsor
19 locations
NCT02978638
Electrical Stimulation for Continence After Spinal Cord Injury
NA
Active, not recruiting
10 participants
Started: Sep 30, 2014 · Completed: Sep 28, 2025
3 conditions
6 sponsors
4 locations
NCT02095249
Prostate Hypoxia - TIC
NA
Active, not recruiting
39 participants
Started: Sep 30, 2014 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT02223208
Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas
PHASE1/PHASE2
Active, not recruiting
89 participants
Started: Sep 30, 2014 · Completed: Feb 28, 2026
5 conditions
1 sponsor
27 locations
NCT02246374
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
NA
Active, not recruiting
7 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06243302
Anal Fistulae Internal Opening Closure by OTSC Clip After Video Assisted Tract Fulguration
N/A
Active, not recruiting
60 participants
Started: Sep 30, 2014 · Completed: Apr 1, 2024
1 condition
1 sponsor
1 location
NCT02347254
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
NA
Active, not recruiting
6 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT02259621
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
PHASE2
Active, not recruiting
39 participants
Started: Sep 30, 2014 · Completed: Oct 31, 2027
1 condition
2 sponsors
5 locations
NCT02257554
Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery
N/A
Active, not recruiting
437 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02240836
Energy Balance and Breast Cancer Aspects-II
NA
Active, not recruiting
545 participants
Started: Sep 30, 2014 · Completed: Oct 31, 2027
4 conditions
3 sponsors
2 locations
NCT02207049
The Effect of Snack Consumption on Energy Intake in Preschoolers
NA
Active, not recruiting
20 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT01646034
High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
PHASE3
Active, not recruiting
74 participants
Started: Sep 30, 2014 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT02333760
Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Sep 30, 2014 · Completed: Oct 31, 2032
1 condition
1 sponsor
2 locations
NCT03672110
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
PHASE3
Active, not recruiting
400 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT02204085
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2
Active, not recruiting
33 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
Previous
1
More pages
395
396
397
398
399
400
401
More pages
431
Next